Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,717.00    -37.00 (-2.11%)
Bid:
1,715.00
Ask:
1,717.00
Spread: 2.00 (0.117%)
Market Cap: £5.50b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Kiskadee update

19 Jan 2015 08:22

RNS Number : 4890C
Hiscox Ltd
19 January 2015
 



 

 

Hiscox announces strong inflows to the Kiskadee ILS Funds

 

 

Hamilton, Bermuda, (19 January, 2015) - Hiscox today announces that total assets under management in its Kiskadee insurance-linked strategies (ILS) funds, have grown to over $400 million at 1 January 2015. Commitments from existing investors have been complemented by strong inflows from new investors, and Kiskadee has also received firm commitments of additional capital for deployment between now and the summer 2015 reinsurance renewal season.

 

The Kiskadee Diversified Fund Ltd and Kiskadee Select Fund Ltd are actively managed open-ended Bermuda domiciled funds. The Kiskadee funds offer investors greater capital efficiency and market access than traditional direct collaterelised ILS funds through their alignment with Hiscox. This structure enables the construction of investible portfolios from a broad and more diverse universe of reinsurance and retrocession risks.

 

Jeremy Pinchin, CEO, Hiscox Re, commented "Our Kiskadee funds combine superior risk selection with diversified market access provided by the Hiscox Group. We believe this is a truly distinctive offering and so are pleased at the enthusiastic response from new and existing investors. Hiscox has a long history of managing alternative forms of capital. Kiskadee is a natural continuation of working with like-minded, long-term partners and offering enhanced solutions to our reinsurance clients."

 

Ends

 

For further information please contact:

Hiscox Ltd

Kylie O'Connor +44 (0) 20 7448 6656 Kylie.O'Connor@HISCOX.com

 

Brunswick

Tom Burns +44 (0) 20 7404 5959 TBurns@brunswickgroup.com 

 

Notes to editors

 

About Kiskadee

Kiskadee Investment Managers, a wholly owned subsidiary of specialist insurer Hiscox, provides investors with the access to the substantial insurance and reinsurance resources of the Hiscox Group. In addition to our flagship Kiskadee Diversified and Kiskadee Select Funds the investment management platform offers single investor funds and bespoke vehicles for tailored insurance, reinsurance portfolios and larger investment allocations.

 

 

About Hiscox

 

Hiscox, the international specialist insurer, is headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). There are three main underwriting divisions in the Group - Hiscox London Market, Hiscox Re and Hiscox Retail (which includes Hiscox UK and Europe, Hiscox Guernsey, Hiscox USA and subsidiary brand, DirectAsia). Hiscox underwrites internationally traded, bigger ticket business and reinsurance through Hiscox Re and Hiscox London Market. Through its retail businesses in the UK, Europe and the US Hiscox offers a range of specialist insurance for professionals and business customers, as well as homeowners. For further information, visit www.hiscoxgroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVKLBFEFFLBBF
Date   Source Headline
1st Jun 202612:11 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSNotice of dividend currency exchange rate
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20262:52 pmRNSNotification of transactions
15th May 20262:43 pmRNSNotification of transactions
14th May 20265:09 pmRNSHiscox 2026 AGM Results
14th May 20265:00 pmRNSSyndicates 33 and 6104 – results and estimates
14th May 20264:53 pmRNSDirector Declaration
11th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSQ1 2026 Trading Statement
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20261:57 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:57 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20262:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20261:05 pmRNSNotice of 2026 AGM and 2025 Annual Report
16th Mar 20261:05 pmRNSNotice of 2026 AGM and 2025 Annual Report
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20269:30 amRNSSyndicates 33 and 6104 – results and estimates
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202612:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:01 amRNSAnnouncement of share repurchase programme
25th Feb 20267:00 amRNSFull Year Results
2nd Feb 202612:33 pmRNSTotal Voting Rights
15th Jan 20267:00 amRNSTR-1: Standard notification of major shareholding
9th Jan 20263:39 pmRNSTR-1: Standard notification of major shareholding
9th Jan 20267:00 amRNSTR-1: Standard notification of major shareholding
2nd Jan 20263:25 pmRNSHiscox Ltd - Total Voting Rights
22nd Dec 20257:00 amRNSCompletion of $275m share repurchase programme
22nd Dec 20257:00 amRNSCompletion of $275m share repurchase programme
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.